{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:01:00Z","timestamp":1780426860406,"version":"3.54.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,26]]},"abstract":"<jats:p>\n                    Background and Objectives: Prior research has examined immune cell involvement in bladder cancer (BCa). This Mendelian randomization (MR) study investigated causal links between 731 immune cell traits and BCa risk, identifying potential immunotherapy targets. Immune cell data came from a Sardinian cohort (3757 individuals), and BCa data from genome-wide association studies. We used inverse variance weighting as the main analysis, with MR-Egger and weighted median methods for validation. Stability checks included sensitivity analyses. Sixteen immune traits (related to 4 immune signals: MFI, RC, AC, MP) showed significant BCa associations. Five increased risk (OR\u2005&gt;\u20051,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05), while 11 were protective (OR\u2005&lt;\u20051,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). No reverse causality, heterogeneity, or horizontal pleiotropy was found (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05). This MR analysis demonstrates complex causal relationships between immune cell traits and BCa, offering new insights for immunotherapy and prevention.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000044268","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:02:37Z","timestamp":1759248157000},"page":"e44268","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Causal relationship between immune cells and bladder cancer: A bidirectional Mendelian randomization study"],"prefix":"10.1097","volume":"104","author":[{"given":"Anneng","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaole","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuwen","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2285-3864","authenticated-orcid":false,"given":"Xiaodong","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260602","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends.","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur Urol"},{"key":"R2-20260602","doi-asserted-by":"crossref","first-page":"104539","DOI":"10.1016\/j.yrtph.2019.104539","article-title":"Arsenic exposure: a public health problem leading to several cancers.","volume":"110","author":"Palma-Lara","year":"2020","journal-title":"Regul Toxicol Pharmacol"},{"key":"R3-20260602","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"key":"R4-20260602","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments.","volume":"400","author":"Comperat","year":"2022","journal-title":"Lancet"},{"key":"R5-20260602","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.3390\/ijms23094969","article-title":"Elevated Expression of the Immune Checkpoint Ligand CD276 (B7-H3) in urothelial carcinoma cell lines correlates negatively with the cell proliferation.","volume":"23","author":"Harland","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R6-20260602","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12885-023-10576-0","article-title":"Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer.","volume":"23","author":"Jung","year":"2023","journal-title":"BMC Cancer"},{"key":"R7-20260602","doi-asserted-by":"crossref","first-page":"754845","DOI":"10.3389\/fonc.2021.754845","article-title":"ACSL4 expression is associated with CD8+ T Cell infiltration and immune response in bladder cancer.","volume":"11","author":"Luo","year":"2021","journal-title":"Front Oncol"},{"key":"R8-20260602","doi-asserted-by":"crossref","first-page":"544610","DOI":"10.3389\/fonc.2020.544610","article-title":"Identification of four immune subtypes in bladder cancer based on immune gene sets.","volume":"10","author":"Tang","year":"2020","journal-title":"Front Oncol"},{"key":"R9-20260602","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12672-024-01008-x","article-title":"Prognostic significance and immune landscape of a cell cycle progression-related risk model in bladder cancer.","volume":"15","author":"Tuo","year":"2024","journal-title":"Discover Oncol"},{"key":"R10-20260602","doi-asserted-by":"crossref","first-page":"153782","DOI":"10.1016\/j.tox.2024.153782","article-title":"Single-cell and multi-omics analyses highlight cancer-associated fibroblasts-induced immune evasion and epithelial mesenchymal transition for smoking bladder cancer.","volume":"504","author":"Wu","year":"2024","journal-title":"Toxicology"},{"issue":"Supple3","key":"R11-20260602","doi-asserted-by":"crossref","first-page":"znad101.094","DOI":"10.1093\/bjs\/znad101.094","article-title":"O094 Urinary-derived immune cell profiling to predict bladder cancer progression and treatment response.","volume":"110","author":"Natarajan","year":"2023","journal-title":"Br J Surg"},{"key":"R12-20260602","doi-asserted-by":"crossref","first-page":"852708","DOI":"10.3389\/fgene.2022.852708","article-title":"The immune cell infiltration patterns and characterization score in bladder cancer to identify prognosis.","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Genet"},{"key":"R13-20260602","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3892\/ol.2020.11750","article-title":"Prognostic value of immune cell infiltration in bladder cancer: a gene expression-based study.","volume":"20","author":"Wang","year":"2020","journal-title":"Oncology Letters"},{"key":"R14-20260602","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1681\/ASN.2016010098","article-title":"Mendelian randomization as an approach to assess causality using observational data.","volume":"27","author":"Sekula","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R15-20260602","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies.","volume":"23","author":"Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R16-20260602","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/bmjebm-2022-112149","article-title":"How to interpret studies using Mendelian randomisation.","volume":"28","author":"Kim","year":"2023","journal-title":"BMJ Evid Based Med"},{"key":"R17-20260602","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy.","volume":"52","author":"Orru","year":"2020","journal-title":"Nat Genet"},{"key":"R18-20260602","doi-asserted-by":"crossref","first-page":"101577","DOI":"10.1016\/j.canep.2019.101577","article-title":"Reporting and guidelines for mendelian randomization analysis: a systematic review of oncological studies.","volume":"62","author":"Lor","year":"2019","journal-title":"Cancer Epidemiol"},{"key":"R19-20260602","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1186\/s12888-023-05081-4","article-title":"Causal role of immune cells in schizophrenia: Mendelian randomization (MR) study.","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Psychiatry"},{"key":"R20-20260602","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization.","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"R21-20260602","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R22-20260602","doi-asserted-by":"crossref","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","article-title":"Evaluating the potential role of pleiotropy in Mendelian randomization studies.","volume":"27","author":"Hemani","year":"2018","journal-title":"Hum Mol Genet"},{"key":"R23-20260602","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR Statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"R24-20260602","doi-asserted-by":"crossref","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","article-title":"Guidelines for performing Mendelian randomization investigations: update for summer 2023.","volume":"4","author":"Burgess","year":"2019","journal-title":"Wellcome Open Res"},{"key":"R25-20260602","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/bioe.13270","article-title":"The Declaration of Helsinki in bioethics literature since the last revision in 2013.","volume":"38","author":"Ehni","year":"2024","journal-title":"Bioethics"},{"key":"R26-20260602","doi-asserted-by":"crossref","first-page":"e15350","DOI":"10.1111\/1756-185X.15350","article-title":"The causal role of immune cells in primary Sjogren\u2019s syndrome: a two-sample Mendelian randomization.","volume":"27","author":"Liu","year":"2024","journal-title":"Int J Rheumatic Dis"},{"key":"R27-20260602","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/ijc.34281","article-title":"CD25: a potential tumor therapeutic target.","volume":"152","author":"Peng","year":"2023","journal-title":"Int J Cancer"},{"key":"R28-20260602","doi-asserted-by":"crossref","first-page":"11450","DOI":"10.18632\/oncotarget.7199","article-title":"Frequency of CD4+CD25+Foxp3+ cells in peripheral blood in relation to urinary bladder cancer malignancy indicators before and after surgical removal.","volume":"7","author":"Jozwicki","year":"2016","journal-title":"Oncotarget"},{"key":"R29-20260602","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1084\/jem.20171761","article-title":"Microbial symbionts regulate the primary Ig repertoire.","volume":"215","author":"Chen","year":"2018","journal-title":"J Exp Med"},{"key":"R30-20260602","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/intimm\/3.12.1273","article-title":"Comparison of IgD+ and IgD- thoracic duct B lymphocytes as germinal center precursor cells in the rat.","volume":"3","author":"Vonderheide","year":"1991","journal-title":"Int Immunol"},{"key":"R31-20260602","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.trecan.2023.07.013","article-title":"CD4(+) T cells help myeloid-mediated killing of immune-evasive tumors.","volume":"9","author":"Wu","year":"2023","journal-title":"Trends Cancer"},{"key":"R32-20260602","first-page":"4234","article-title":"CD4(+) T cell exhaustion leads to adoptive transfer therapy failure which can be prevented by immune checkpoint blockade.","volume":"10","author":"Fu","year":"2020","journal-title":"Am J Cancer Res"},{"key":"R33-20260602","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.leukres.2009.06.005","article-title":"Depletion of peripheral blood B cells with Rituximab and phenotype characterization of the recovering population in a patient with follicular lymphoma.","volume":"34","author":"Abulayha","year":"2010","journal-title":"Leuk Res"},{"key":"R34-20260602","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/neuonc\/noad198","article-title":"Immune signatures of checkpoint inhibitor-induced autoimmunity-A focus on neurotoxicity.","volume":"26","author":"Muller-Jensen","year":"2024","journal-title":"Neuro Oncol"},{"key":"R35-20260602","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrrheum.2016.147","article-title":"Altered dendritic cell functions in autoimmune diseases: distinct and overlapping profiles.","volume":"12","author":"Coutant","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"R36-20260602","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5483\/BMBRep.2021.54.1.224","article-title":"The role of dendritic cells in tumor microenvironments and their uses as therapeutic targets.","volume":"54","author":"Kim","year":"2021","journal-title":"BMB Reports"},{"key":"R37-20260602","doi-asserted-by":"crossref","first-page":"102","DOI":"10.14715\/cmb\/2018.64.10.16","article-title":"Sensitization of cisplatin resistant bladder tumor by combination of cisplatin treatment and co-culture of dendritic cells with apoptotic bladder cancer cells.","volume":"64","author":"Zhang","year":"2018","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"R38-20260602","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3389\/fimmu.2019.01068","article-title":"L-selectin: a major regulator of leukocyte adhesion, migration and signaling.","volume":"10","author":"Ivetic","year":"2019","journal-title":"Front Immunol"},{"key":"R39-20260602","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.3390\/cancers12113342","article-title":"Plasmacytoid Dendritic Cell (pDC) infiltration correlate with tumor infiltrating lymphocytes, cancer immunity, and better survival in Triple Negative Breast Cancer (TNBC) More Strongly than Conventional Dendritic Cell (cDC).","volume":"12","author":"Oshi","year":"2020","journal-title":"Cancers"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044268","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:02:34Z","timestamp":1780423354000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":39,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044268","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"2024-10-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}